Riverview Trust Co - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Riverview Trust Co ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21,591
+10.6%
4760.0%0.02%
+5.6%
Q2 2023$19,530
+14.8%
4760.0%0.02%
+12.5%
Q1 2023$17,012
+94411.1%
4760.0%0.02%
-5.9%
Q4 2022$18
-99.9%
4760.0%0.02%
-15.0%
Q3 2022$21,000
+16.7%
4760.0%0.02%
+25.0%
Q2 2022$18,0000.0%4760.0%0.02%
+23.1%
Q1 2022$18,0004760.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders